We thus proposed that pioglitazone improves PVAT microenvironments and aortic stiffening in obesity via multiple PPARγ target genes in the cells, such as macrophages and fibroblasts, residing within the PVAT. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.